APA (7th ed.) Citation

Wang, P., Guo, W., Liu, S., Li, S., Li, J., Ding, B., . . . Feng, Y. (2025). Novel Pt@PCN-Cu-induced cuproptosis amplifies αPD-L1 immunotherapy in pancreatic ductal adenocarcinoma through mitochondrial HK2-mediated PD-L1 upregulation. Journal of Experimental & Clinical Cancer Research (17569966), 44(1), 1. https://doi.org/10.1186/s13046-025-03409-4

Chicago Style (17th ed.) Citation

Wang, Pengyu, et al. "Novel Pt@PCN-Cu-induced Cuproptosis Amplifies αPD-L1 Immunotherapy in Pancreatic Ductal Adenocarcinoma Through Mitochondrial HK2-mediated PD-L1 Upregulation." Journal of Experimental & Clinical Cancer Research (17569966) 44, no. 1 (2025): 1. https://doi.org/10.1186/s13046-025-03409-4.

MLA (9th ed.) Citation

Wang, Pengyu, et al. "Novel Pt@PCN-Cu-induced Cuproptosis Amplifies αPD-L1 Immunotherapy in Pancreatic Ductal Adenocarcinoma Through Mitochondrial HK2-mediated PD-L1 Upregulation." Journal of Experimental & Clinical Cancer Research (17569966), vol. 44, no. 1, 2025, p. 1, https://doi.org/10.1186/s13046-025-03409-4.